Role of nitric oxide in obesity-induced β cell disease

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 290-295

  Shimabukuro, Michio ^a,b   Ohneda, Makoto ^a,b,d   Lee, Young ^a,b   Unger, Roger H ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Inducible nitric oxide synthase; Nitric oxide; Obesity; Zucker diabetic fatty rat

Indexed keywords

AMINOGUANIDINE; FATTY ACID; INSULIN; NICOTINAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; RAT;

EID: 0030852877     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119534     Document Type: Article

References (37)

1. DeFronzo, R.A. 1988. The triumvirate: β cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:667-687.
2. Campbell, P.J., M.G. Carlson, and N. Nurjhan. 1994. Fat metabolism in human obesity. Am. J. Physiol. 266:E600-E605.
3. Randle, P.J., C.N. Hales, P.B. Garland, and E.A. Newsholme. 1963. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. i;785-789.
4. Ferrannini, E., E.J. Barrett, S. Bevilacqua, and R.A. DeFronzo. 1983. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72:1737-1747.
5. Groop, L.C., C. Saluranta, M. Shank, R.C. Bonnadonna, E. Ferranini, and R.A. DeFronzo. 1991. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 72:96-107.
6. McGarry, J.D. 1992. What if Minkowski had been ageustic? Science (Wash. DC). 258:766-774.
7. Sako, Y., and V.E. Grill. 1990. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology. 127: 1580-1589.
8. Zhou, Y.P., and V.E. Grill. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93:870-876.
9. Capito, K., S.E. Hansen, C.J. Hedeskov, H. Islin, and P. Thams. 1992. Fat-induced changes in mouse pancreatic islet insulin secretion, insulin biosynthesis and glucose metabolism. Acta Diabetol. 28:193-198.
10. Elks, M.L. 1993. Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology. 133:208-214.
11. Lee, Y., H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry, and R.H. Unger. 1994. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte β-cell relationships. Proc. Natl. Acad. Sci. USA. 91:10878-10882.
12. Unger, R.H. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes. 44:863-870.
13. Corbett, J., J. Wang, M. Sweetland, J. Lancaster, and M. McDaniel. 1992. Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. J. Clin. Invest. 90:2384-2391.
14. Corbett, J., and M. McDaniel. 1995. Intraislet release of interleukin 1 inhibits β-cell function by inducing β-cell expression of inducible nitric oxide synthase. J. Exp. Med. 181:559-568.
15. Eizirik, D.L., C. Delaney, M. Green, J. Cunningham, J. Thorpe, D. Pipeleers, C. Hellerstrom, and I. Green. 1996. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell. Endocrinol. 118:71-83.
16. McDaniel, M.L., G. Kwon, J.R. Hill, C.A. Marshall, and J.A. Corbett. 1996. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:24-32.
17. Kaneto, H., J. Fujii, H.G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. 1995. Apototic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes. 44:733-738.
18. Peterson, R.G.,W.N. Shaw, M. Neal, L.A. Little, and J. Eichberg. 1990. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News. 32:16-19.
19. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
20. Nunokawa, Y., N. Ishida, and S. Tanaka. 1993. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 191:89-94.
21. Milburn, J.L., Jr., H. Hirose, Y. Lee, Y. Nagasawa, A. Ogawa, M. Ohneda, H. BeltrandelRio, C.B. Newgard, J. Johnson, and R.H. Unger. 1995. Pancreatic β-cells in obesity: evidence for induction of functional, morphologic and metabolic abnormalities by increased long-chain fatty acids. J. Biol. Chem. 270:1295-1299.
22. Hirose, H., Y. Lee, L. Inman. Y. Nagasawa, J. Johnson, and R.H. Unger. 1996. Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats. J. Biol. Chem. 271:5633-5637.
23. Grodsky, G.M., and R.E. Fanska. 1975. The in vitro perfused pancreas. Methods Enzymol. 39:364-372.
24. Orci, L., M. Ravazzola, D. Baetens, L. Inman, M. Amherdt, R.G. Peterson, C.B. Newgard, J.H. Johnson, and R.H. Unger. 1990. Evidence that down-regulation of β-cell glucose transporters in non-insulin-dependent diabetes may be the cause of hyperglycemia. Proc. Nati. Acad. Sci. USA. 87:9953-9957.
25. Weibel, E.R. 1979. Point counting methods. In Stereologic Methods. E.R. Weibel, editor. London, Academic, London, 101-161.
26. Akabane, A. 1995. Nicotinamide inhibits IRF-1 mRNA induction and prevents IL-1β-induced nitric oxide synthase expression in pancreatic β-cells. Biochem. Biophys. Res. Commun. 215:524-530.
27. Corbett, J.H., and M.L. McDaniel. 1996. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol. 268:398-408.
28. Joshi, P.C., J.B. Grogan, and K.R. Thomae. 1996. Effect of aminoguanidine on in vivo expression of cytokines and inducible nitric oxide synthase in the lungs of endotoxemic rats. Res. Commun. Mol. Pathol. Pharmacol. 91:339-346.
29. Pozzilli, P., P.D. Browne, and H. Kolb. 1996. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. Diabetes Care. 19:1357-1363.
30. Thorens, B., Y.J. Wu, J.L. Leahy, and G.C. Weir. 1992. The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. J. Clin. Invest. 90:77-85.
31. + depletion. Biochem. Biophys. Res. Commun. 199:1270-1277.
32. Moncada, S., R.M. Palmer, and H.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
33. Zhang, J., V.L. Dawson, T.M. Dawson, and S.H. Snyder. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (Wash. DC). 263:687-689.
34. G-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology. 135:849-853.
35. Lipton, S.A., Y. Chol, Z. Pan, S.Z. Lei, H.V. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, and J.S. Stamler. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (Lond.). 364:626-632.
36. Phillips, M.S., Q. Liu, H. Hammond, V. Dugan, P. Hey, C.T. Caskey, and J.F. Hess. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13:18-19.
37. Lee, Y., H. Hirose, Y.-T. Zhou, V. Esser, J. McGarry, and R.H. Unger. 1997. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes. 46:408-413.